Clinical Trials
15 trialsNCT04895735 2026-06-04
MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT02780310 2026-06-03
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT07616141 2026-06-01
NAET4-SNACC
Eye & ENT Hospital of Fudan University
Phase 2 Not yet recruiting
NCT07320508 2026-05-12
EIC-SNACC
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT07522879 2026-05-12
MRG003-SACC
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT07563088 2026-05-12
SPARE-1st
Eye & ENT Hospital of Fudan University
Not yet recruiting
NCT05074940 2026-05-08
Amivantamab in Adenoid Cystic Carcinoma
University of Cincinnati
Phase 2 Active not recruiting
NCT07162480 2026-05-04
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04973683 2026-04-23
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05377996 2026-04-14
A Study of XMT-1660 in Participants With Solid Tumors
Mersana Therapeutics
Phase 1 Recruiting
NCT07521670 2026-04-13
STRAP
National Cancer Centre, Singapore
Phase 2 Not yet recruiting
NCT06891560 2026-03-20
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed